Webinar on FDA’s Safety Monitoring of Approved Vaccines

Webinar on FDA’s Safety Monitoring of Approved Vaccines
DATE: July 13, 2010

TIME: 2:00pm

LENGTH: 30 minutes

Did you know that FDA’s review of vaccine safety doesn’t stop once a vaccine is approved? Why is it important to have different types of systems to perform safety surveillance for approved vaccines?

On Tuesday, July 13th, FDA will host a webinar that answers questions about the agency’s work to ensure the safety of vaccines. Andrea Sutherland, MD, MPH, Msc, who is a medical officer and Special Assistant to the Director of the Division of Epidemiology in the Office of Biostatistics and Epidemiology in FDA’s Center for Biologics Evaluation and Research, will give an overview and answer questions about vaccine safety surveillance, including the Vaccine Adverse Event Reporting System (or VAERS), and efforts underway to improve safety monitoring. Currently, FDA is working with federal, international, academic, and health care partners to further improve its ability to evaluate the safety of vaccines throughout the lifecycle of products.

After the presentation, there will an opportunity to ask questions.

open here please:
Webinar on FDA’s Safety Monitoring of Approved Vaccines